Trial Profile
Combined therapy with Adefovir and Interferon-Pegylated alfa 2a vs Adefovir alone, in patients affected by chronic hepatitis B, HbeAg negative (The PAC (Peg Adefovir Combination) Study).
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms PAC
- 09 Aug 2011 New trial record